LMR Partners’s Corvus Pharmaceuticals CRVS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-29,858
| Closed | -$94.9K | – | 893 |
|
|
2025
Q1 | $94.9K | Buy |
+29,858
| New | +$94.9K | ﹤0.01% | 708 |
|
|
2024
Q4 | – | Hold |
0
| – | – | – | 832 |
|
|
2023
Q2 | – | Sell |
-30,000
| Closed | -$27.3K | – | 817 |
|
|
2023
Q1 | $27.3K | Hold |
30,000
| – | – | ﹤0.01% | 970 |
|
|
2022
Q4 | $25.5K | Hold |
30,000
| – | – | ﹤0.01% | 1059 |
|
|
2022
Q3 | $25K | Hold |
30,000
| – | – | ﹤0.01% | 1132 |
|
|
2022
Q2 | $30K | Hold |
30,000
| – | – | ﹤0.01% | 1199 |
|
|
2022
Q1 | $49K | Hold |
30,000
| – | – | ﹤0.01% | 1188 |
|
|
2021
Q4 | $72K | Hold |
30,000
| – | – | ﹤0.01% | 1112 |
|
|
2021
Q3 | $145K | Buy |
+30,000
| New | +$145K | ﹤0.01% | 942 |
|